A carregar...
Effect of PREDICT on chemotherapy/trastuzumab recommendations in HER2-positive patients with early-stage breast cancer
PREDICT is an online prognostication tool for early-stage breast cancer, which incorporates human epidermal growth factor 2 (HER2) status and stratifies absolute treatment benefits for hormone therapy, chemotherapy and trastuzumab. The present study compared historical multidisciplinary team (MDT) d...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4214477/ https://ncbi.nlm.nih.gov/pubmed/25364461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2014.2589 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|